Skip to content

The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure Ulcers

The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for the Treatment of Pressure Ulcers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03038490
Enrollment
90
Registered
2017-01-31
Start date
2016-12-01
Completion date
2020-03-31
Last updated
2017-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure Ulcers Stage III, Pressure Ulcer, Stage IV

Brief summary

To investigate whether an oral nutritional supplement of a mixture of arginine, glutamine and HMB for a maximum period of four weeks is more beneficial than the standard dietary approach to the healing of pressure ulcers, and to examine whether the use of it can reduce admissions and length of hospitalizations for these patients.

Detailed description

All patients would be assessed by a dietitian to ensure them receiving nutritional support of at least 30 kcal/kg/day and of at least 1.2 g/kg/day of protein regardless of feeding method. During the study period, vitamin C and zinc supplement would not be given. Nutritional supplement other than that provided by the dietitian to meet the energy and protein requirement would not be given. The pressure ulcers would be cared according to the Basic nursing standards for patient care: Wound dressing - Version 5 published by the Hospital Authority Head Office. The treatment group would also be given 2 Sackets of a mixture of arginine, glutamine and HMB (ABOUND) every day for a maximum period of 4 weeks, either orally or via enteral feeding.

Interventions

DIETARY_SUPPLEMENTABOUND

an oral mixture of arginine, glutamine and beta-hydroxy-beta-methylbutyrate

Sponsors

Wong Tai Sin Hospital
CollaboratorUNKNOWN
Our Lady of Maryknoll Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Inpatients of medical and geriatric wards of OLMH and WTSH 2. Aged 18 and older with stage III - IV lesions 3. Patients fed orally or through feeding tubes were included

Exclusion criteria

1. Patients with history of using the nutritional supplement (ABOUND) in previous three months 2. Patients with cellulitis, wounds with purulent discharge or osteomyelitis or sepsis 3. Patients requiring protein restriction 4. Patients with poorly controlled diabetes mellitus (latest HbA1C \> 8.5) (healing process may be affected 5. Patients under palliative care

Design outcomes

Primary

MeasureTime frame
percentage change in pressure ulcer area4 weeks
change in Pressure Ulcer Scale for Healing (PUSH)4 weeks

Secondary

MeasureTime frame
number of hospital admissionssix months
length of hospitalisationsix months

Countries

Hong Kong

Contacts

Primary ContactKwok Man Lo, FHKAM (Med)
lokm1@ha.org.hk
Backup ContactKa Ying Doris Miu, FHKAM (Med)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026